Status: Recruiting,
Condition Summary: Eye Diseases
Intrascleral Lens Fixation May Increase Higher-Order Aberrations
Extending intraocular lenses (IOLs) widely for intrascleral fixation may increase their higher-order aberrations, but not enough to significantly affect postoperative vision, a new study from Japan suggests. Reuters Health Information
Does Air Pollution Kill?
(MedPage Today) — Experts sound off on two new studies linking pollution with early mortality
Hospitals Push Docs to Improve Their Bedside Manners
(MedPage Today) — Doctors encouraged to be better listeners, serve patients’ needs
Califf Nomination for FDA Chief Gets Mostly High Marks
(MedPage Today) — But ties with industry may be an issue
Aerie Pharmaceuticals Reports Positive Rhopressa™ Phase 3 Efficacy Results
IRVINE, Calif.–(BUSINESS WIRE)–Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of first-in-class glaucoma therapies, today reported the successful results of its second Phase 3 trial for Rhopressa™, a novel once-daily, triple-action eye drop being tested for its ability to lower intraocular pressure (IOP) in patients with glaucoma or ocular hypertension. The trial achieved its primary efficacy endpo